Rui Tato Marinho
University of Lisbon(PT)University of Antwerp(BE)Universidade Federal de Santa Catarina(BR)Lisbon School of Design(PT)Department of Aerospace Science and Technology(BR)Administração Regional de Saúde de Lisboa e Vale do Tejo(PT)Centro Hospitalar Lisboa Norte(PT)Infectious Diseases Institute(UG)Institute of Biology of Karelian Research Centre(RU)Università degli Studi Internazionali di Roma(IT)Hospital de Santa Maria(PT)Centro Universitário Internacional(MX)Universidade Estadual Paulista (Unesp)(BR)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease and Transplantation, Inflammatory Bowel Disease
Most-Cited Works
- → ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV(2014)691 cited
- → Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin(2014)515 cited
- → The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm(2014)484 cited
- → A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel(2011)406 cited
- → Historical epidemiology of hepatitis C virus (HCV) in selected countries(2014)241 cited
- → Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis(2017)227 cited